Literature DB >> 984788

Concentrations of trimethoprim-sulfamethoxazole in blood after a single, large oral dose.

T T Yoshikawa, L B Guze.   

Abstract

Concentrations of trimethoprim (TMP) and sulfamethoxazole (SMZ) in blood were determined in seven healthy volunteers after ingestion of 720 mg of TMP and 3,600 mg of SMZ (nine tablets of TMP-SMZ, 1:5 ratio) as a single oral dose. The mean levels of drug in blood achieved during the first 8 h after drug administration ranged from 6.12 to 8.32 mug/ml for TMP and 98 to 120 mug/ml for SMZ. These concentrations easily exceeded the previously reported minimal inhibitory concentrations for clinical isolates of Neisseria gonorrhoeae. The combination of TMP-SMZ given as a single, large oral dose may be a useful therapeutic regimen for patients with uncomplicated gonorrhea and susceptible microorganisms.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 984788      PMCID: PMC429771          DOI: 10.1128/AAC.10.3.462

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  Trimethoprim-sulphamethoxazole in gonorrhoea.

Authors:  S Ullman; A M Niordson; H Zachariae
Journal:  Acta Derm Venereol       Date:  1971       Impact factor: 4.437

2.  Sulphamethoxazole combined with 2-4-diamino-pyrimidines in the treatment of gonorrhoea.

Authors:  D J Wright; A S Grimble
Journal:  Br J Vener Dis       Date:  1970-02

3.  Spectrofluorimetric method for the determination of trimethoprim in body fluids.

Authors:  D E Schwartz; B A Koechlin; R E Weinfeld
Journal:  Chemotherapy       Date:  1969       Impact factor: 2.544

4.  Therapeutic trial of trimethoprim as a potentiator of sulphonamides in gonorrhoea.

Authors:  G W Csonka; G J Knight
Journal:  Br J Vener Dis       Date:  1967-09

5.  Comparison of trimethoprim-sulphamethoxazole and penicillin in the treatment of gonorrhoea.

Authors:  J D Mahony; J S McCann; J R Harris
Journal:  Br J Vener Dis       Date:  1973-12

6.  Gonorrhea in women: treatment with sulfamethoxazole and trimethoprim.

Authors:  C B Schofield; G Masterton; M Moffett; M I McGill
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

7.  Treatment of gonorrhoea with trimethoprim-sulphamethoxazole in Uganda.

Authors:  O P Arya; C H Pearson; S K Rao; R Blowers
Journal:  Br J Vener Dis       Date:  1970-06

8.  Comparison of in vitro susceptibility of Neisseria gonorrhoeae to trimethoprim-sulfamethoxazole on three different media.

Authors:  T T Yoshikawa; S Miyamoto; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1975-11       Impact factor: 5.191

  8 in total
  3 in total

1.  Pharmacokinetics and tolerance of a single twelve-tablet dose of trimethoprim (960 mg)-sulfamethoxazole (4,800 mg).

Authors:  R J Fass; R B Prior; R L Perkins
Journal:  Antimicrob Agents Chemother       Date:  1977-07       Impact factor: 5.191

2.  Sulfamethoxazole-trimethoprim synergism for Neisseria gonorrhoeae.

Authors:  M F Rein; W C Elliott; J M Swenson; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

3.  A Physiologically-Based Pharmacokinetic Model of Trimethoprim for MATE1, OCT1, OCT2, and CYP2C8 Drug-Drug-Gene Interaction Predictions.

Authors:  Denise Türk; Nina Hanke; Thorsten Lehr
Journal:  Pharmaceutics       Date:  2020-11-10       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.